RSV is a highly contagious virus affecting the respiratory system, especially dangerous for infants, young children, and ...

Respiratory viruses can remain hidden in immune cells in the lungs long after the initial symptoms of an infection have ...

In another positive development, Pfizer won a bid in a London court to invalidate two of GSK Plc’s GSK patents relating to its respiratory syncytial virus (RSV) vaccine. Also Read: UK Chooses Pfizer ...

Pfizer on Monday won a bid in a London court to invalidate two of GSK's patents relating to a respiratory syncytial virus ...

Quebec is rolling out its fall vaccination campaign against respiratory viruses, as contagion levels of COVID-19 and other ...

Illness from RSV is considered an infectious disease, usually leading to an infection of the upper respiratory tract but ...

Low uptake in the RSV and COVID vaccine markets is not surprising, an analyst says, and could mean weak earnings for ...

The RSV vaccine is unequivocally recommended for adults who are residents in skilled nursing and assisted living facilities.

Infections caused by the latest variant have symptoms including fever, chills, fatigue, cough, congestion and headache.

Rates of sudden infant deaths increased during the covid-19 pandemic, a new analysis suggests - and altered transmission of illnesses such as respiratory syncytial virus (RSV) might be linked to ...

GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) today announced that Arexvy has been approved in Malaysia for respiratory ...

The complex shape of respiratory syncytial virus (RSV) is one hurdle limiting the development of treatments for an infection ...